Health Disparities among Patients with Cancer Who Received Molecular Testing for Biomarker-Directed TherapyElisabeth I. Heath, John L. Marshall, Gregory Dyson et al.|Cancer Research Communications|2024Cited by 6
Supplementary Fiugre S4 from Health Disparities among Patients with Cancer Who Received Molecular Testing for Biomarker-Directed TherapyElisabeth I. Heath, John L. Marshall, Gregory Dyson et al.|Unknown|2024Cited by 0
Supplementary Figure S5 from Health Disparities among Patients with Cancer Who Received Molecular Testing for Biomarker-Directed TherapyElisabeth I. Heath, John L. Marshall, Gregory Dyson et al.|Unknown|2024Cited by 0
Data from Health Disparities among Patients with Cancer Who Received Molecular Testing for Biomarker-Directed TherapyElisabeth I. Heath, John L. Marshall, Gregory Dyson et al.|Unknown|2024Cited by 0
Supplementary Table S2 from Health Disparities among Patients with Cancer Who Received Molecular Testing for Biomarker-Directed TherapyElisabeth I. Heath, John L. Marshall, Gregory Dyson et al.|Unknown|2024Cited by 0